US46333X1081
US46333X1081
Ironwood Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 631.22M EUR | 695.66M EUR | 577.79M EUR | 549.51M EUR |
Enterprise Value | 957.22M EUR | 1.01B EUR | 954.68M EUR | 931.85M EUR |
Valuation Multiples | ||||
Trailing P/E | 5.03x | 5.36x | 5.65x | 8.95x |
Forward P/E | 2.55x | -- | -- | -- |
Price to Sales | 1.62x | 1.79x | 1.6x | 2.15x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 2.46x | 2.6x | 2.64x | 3.65x |
EV/EBITDA | 4.02x | 4.16x | 4.58x | 6.95x |
Price to FCF (P/FCF) | 5.18x | 3.75x | 5.15x | 5.13x |
EV/FCF | 7.86x | 5.46x | 8.51x | 8.7x |
FCF Yield | 19.3% | 26.67% | 19.42% | 19.49% |